Enikő Vetlényi

Inhibition of Metabolic Shift can Decrease Therapy Resistance in Human High-Grade Glioma Cells

J. Pápay, A. Sebestyén, A. Jeney, 2019, Pathology & Oncology Research.

Characterisation of 3D Bioprinted Human Breast Cancer Model for In Vitro Drug and Metabolic Targeting

J. Pápay, A. Sebestyén, T. Dankó, 2022, International journal of molecular sciences.

Metabolic Adaptation as Potential Target in Papillary Renal Cell Carcinomas Based on Their In Situ Metabolic Characteristics

E. Sebestyén, K. Mészáros, J. Pápay, 2022, International journal of molecular sciences.

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

N. Nagy, K. Mészáros, Fanni Tóth, 2018, Cancer Cell International.

In Situ Metabolic Characterisation of Breast Cancer and Its Potential Impact on Therapy

A. Tőkés, J. Kulka, A. Sebestyén, 2020, Cancers.

Natrocarbonatites: A hidden product of three-phase immiscibility

C. Szabó, R. Bodnar, A. Fall, 2019, Geology.

Targeting cellular metabolism using rapamycin and/or doxycycline enhances anti-tumour effects in human glioma cells

N. Nagy, K. Mészáros, Fanni Tóth, 2018, Cancer Cell International.

Tumorigenic role of tacrolimus through mTORC1/C2 activation in post-transplant renal cell carcinomas

G. Végső, Á. Márk, T. Dankó, 2024, British journal of cancer.